— Know what they know.
Not Investment Advice

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
1W: -2.6% 1M: -2.7% 3M: -28.5% YTD: -4.0% 1Y: -41.8% 3Y: -54.5% 5Y: -19.2%
¥39.08 ($5.66)
-0.77 (-1.93%)
 
SHH · Healthcare · Biotechnology · ¥50.4B
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥50.4B ($7.3B)
52W Range37.85-80
Volume2,891,756
Avg Volume3,910,734
Beta1.04
Dividend¥0.32
Analyst Ratings
No analyst coverage
Company Info
CEOZhiming Jiang
Employees3,790
SectorHealthcare
IndustryBiotechnology
IPO Date2020-04-29
Websiteystwt.com
No. 31 Kexueyuan Road
Beijing 102206
CN
86 10 5952 8888
About Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms